Thus, TXN is a promising early biomarker of AD, AD patients’ hippocampus tissue sections displayed abnormal TXN1 immunoreactivity and expression pattern, as promising early biomarkers of AD compared to controls (Arodin et al., 2014). This evidence concerns the gene TXN and Alzheimer disease.